Proteomic changes in Alzheimer’s disease associated with progressive Aβ plaque and tau tangle pathologies
Alexa Pichet Binette(Lund University), Oskar Hansson(Eli Lilly (United States)), Erik Stomrud(Lund University), Atul Kumar(Lund University), Olof Strandberg(Lund University), Li‐Huei Tsai(Broad Institute), Niklas Mattsson(Malmö University), Nicola Spotorno(Lund University), Inès Hristovska(Lund University), Gemma Salvadó(Lund University), Chris Gaiteri(Rush University Medical Center), Malin Wennström(Lund University), Jacob W. Vogel(Malmö University), Hansruedi Mathys(University of Pittsburgh), Shorena Janelidze(Lund University), Sebastian Palmqvist(Skåne University Hospital)
Cited by 107
Related Papers
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k
Brain charts for the human lifespan
|Nature|2022|1.8k
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
|The Journal of Prevention of Alzheimer s Disease|2022|1.3k
APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types
|Neuron|2018|1.1k
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
|Nature Communications|2017|927